Autologous haematopoietic stem cell transplantation

Topic Status Incomplete

Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis.

Summary

 

Health Technology Wales researchers searched for evidence on autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis.

Based on the evidence identified, HTW’s Assessment Group concluded to progress this topic to Evidence Appraisal.

Topic Exploration Report

TER107 (07.20)

TER
View PDF

Access our guidance

Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
  • We may like to contact you by email to find out more about how you used the documents.

  • This field is for validation purposes and should be left unchanged.